Do genetic predictors of pain sensitivity associate with persistent widespread pain?
Do genetic predictors of pain sensitivity associate with persistent widespread pain?
Genetic risk factors for pain sensitivity may also play a role in susceptibility to chronic pain disorders, in which subjects have low pain thresholds. The aim of this study was to determine if proposed functional single nucleotide polymorphisms (SNPs) in the GTP cyclohydrolase (GCH1) and μ opioid receptor (OPRM1) genes previously associated with pain sensitivity affect susceptibility to chronic widespread pain (CWP). Pain data was collected using body manikins via questionnaire at three time-points over a four year period from subjects aged 25–25 in the North-West of England as part of a population based cohort study, EPIFUND. CWP was defined at each time point using standard criteria. Three SNPs forming a proposed “pain-protective” haplotype in GCH1 (rs10483639, rs3783641 and rs8007267) and two SNPs in OPRM1 (rs1777971 (A118G) and rs563649) were genotyped in cases with persistent CWP (CWP present at 2 time-points) and controls who were pain-free at all time-points. The expectation-maximisation algorithm was used to estimate haplotype frequencies. The frequency of the “pain-protective” (CAT - C allele of rs10483639, A allele of rs3783641 and T allele of rs8007267) haplotype was compared to the frequency of the other haplotypes between cases and controls using the χ2 test. Allele frequencies and carriage of the minor allele was compared between cases and controls using χ2 tests for the OPRM1 SNPs. The frequency of the proposed GCH1 “pain-protective” haplotype (CAT) did not significantly differ between cases and controls and no significant associations were observed between the OPRM1 SNPs and CWP. In conclusion, there was no evidence of association between proposed functional SNPs, previously reported to influence pain sensitivity, in GCH1 and OPRM1 with CWP. Further evidence of null association in large independent cohorts is required to truly exclude these SNPs as genetic risk factors for CWP.
Holliday, Kate L.
58c01428-143a-4fc8-bd97-eb513573a697
Nicholl, Barbara I.
3922cf66-6e36-44d2-9d8b-1736123e0e53
Macfarlane, Gary J.
e17bbdb7-9d82-42ac-8a0a-09bf10885e3c
Thomson, Wendy
1e15e3f0-5128-496d-a2bd-da122d42ddfa
Davies, Kelly A.
e12e3ee1-0a98-4677-934b-10db47b575f8
McBeth, John
98012716-66ba-480b-9e43-ac53b51dce61
2009
Holliday, Kate L.
58c01428-143a-4fc8-bd97-eb513573a697
Nicholl, Barbara I.
3922cf66-6e36-44d2-9d8b-1736123e0e53
Macfarlane, Gary J.
e17bbdb7-9d82-42ac-8a0a-09bf10885e3c
Thomson, Wendy
1e15e3f0-5128-496d-a2bd-da122d42ddfa
Davies, Kelly A.
e12e3ee1-0a98-4677-934b-10db47b575f8
McBeth, John
98012716-66ba-480b-9e43-ac53b51dce61
Holliday, Kate L., Nicholl, Barbara I., Macfarlane, Gary J., Thomson, Wendy, Davies, Kelly A. and McBeth, John
(2009)
Do genetic predictors of pain sensitivity associate with persistent widespread pain?
Molecular Pain, 5 (56).
(doi:10.1186/1744-8069-5-56).
Abstract
Genetic risk factors for pain sensitivity may also play a role in susceptibility to chronic pain disorders, in which subjects have low pain thresholds. The aim of this study was to determine if proposed functional single nucleotide polymorphisms (SNPs) in the GTP cyclohydrolase (GCH1) and μ opioid receptor (OPRM1) genes previously associated with pain sensitivity affect susceptibility to chronic widespread pain (CWP). Pain data was collected using body manikins via questionnaire at three time-points over a four year period from subjects aged 25–25 in the North-West of England as part of a population based cohort study, EPIFUND. CWP was defined at each time point using standard criteria. Three SNPs forming a proposed “pain-protective” haplotype in GCH1 (rs10483639, rs3783641 and rs8007267) and two SNPs in OPRM1 (rs1777971 (A118G) and rs563649) were genotyped in cases with persistent CWP (CWP present at 2 time-points) and controls who were pain-free at all time-points. The expectation-maximisation algorithm was used to estimate haplotype frequencies. The frequency of the “pain-protective” (CAT - C allele of rs10483639, A allele of rs3783641 and T allele of rs8007267) haplotype was compared to the frequency of the other haplotypes between cases and controls using the χ2 test. Allele frequencies and carriage of the minor allele was compared between cases and controls using χ2 tests for the OPRM1 SNPs. The frequency of the proposed GCH1 “pain-protective” haplotype (CAT) did not significantly differ between cases and controls and no significant associations were observed between the OPRM1 SNPs and CWP. In conclusion, there was no evidence of association between proposed functional SNPs, previously reported to influence pain sensitivity, in GCH1 and OPRM1 with CWP. Further evidence of null association in large independent cohorts is required to truly exclude these SNPs as genetic risk factors for CWP.
Text
holliday-et-al-2009-do-genetic-predictors-of-pain-sensitivity-associate-with-persistent-widespread-pain
- Version of Record
More information
Accepted/In Press date: 23 September 2009
Published date: 2009
Identifiers
Local EPrints ID: 491653
URI: http://eprints.soton.ac.uk/id/eprint/491653
ISSN: 1744-8069
PURE UUID: c5c74ab5-e5b9-40c4-967f-76307e96daf2
Catalogue record
Date deposited: 03 Jul 2024 09:37
Last modified: 12 Jul 2024 02:17
Export record
Altmetrics
Contributors
Author:
Kate L. Holliday
Author:
Barbara I. Nicholl
Author:
Gary J. Macfarlane
Author:
Wendy Thomson
Author:
Kelly A. Davies
Author:
John McBeth
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics